Register
|
Login
Published News
Upcoming News
Submit a New Story
Blogs
Clinical Trials
Conferences & Events
Corporate
Financial
Product
Publications
Research & Development
RSS
4
Vote
Drug Injury Watch: Diet Drug Meridia Has Possible Cardiovascular Risks, Including Stroke, Heart Attack, And Cardiac Death
Posted by
tjlpa
276 days ago (
http://www.drug-injury.com
)
FDA Early Communication About Meridia (Sibutramine) Side Effects Issued by Agency In November 2009
Who Voted for this Story
tjlpa
worldpharmanews
Related Links
Drug Injury Watch: Dr. Dennis Mangano Says On 60 Minutes In February 2008 That Trasylol Should Have Been Recalled As Early As January 2006
Drug Injury Watch: FDA's Proposed Rule About Drug Label Warning Changes Will Lessen Its Power To Protect Us
Patient Lawsuits Against Pharmacuetical Companies For Drug Injuries Might Be Prohibited In U.S.
Drug Injury Watch: Zyprexa And Diabetes: Is This A Tale Of Company Greed Coupled With FDA Failure?
Drug Injury Watch: New Article With 25 Big Pharma Facts, And Free Online Tool To Search MedWatch Report Data
Drug Injury Watch: Did You See Ortho-McNeil's Response To April 6 NYT Article About Ortho Evra And Federal Preemption?
Drug Injury Watch: Ortho Evra, Preemption, And The New York Times: Another Drug Company Response Letter
Drug Injury Watch: April 2008: FDA Web Site Adds Two New Pages For Learning About Drug Safety
Drug Injury Watch: FDA's 2007 Report On Outstanding Post-approval Studies: No Progress Made By Big Pharma
Drug Injury Watch: Digitek Digoxin Recall: Tablets May Be Double The Normal Dose
Comments
Log in to comment
or register
here
.
Subscribe
Enter your email address:
Delivered by
FeedBurner
Top Users
Tag cloud
Live
Comments